Current Landscape in the Pharmacotherapy of Sickle Cell Disease (SCD) - Pharmaceutical Society of Jamaica
IJNS | Free Full-Text | Sickle Cell Disease—Genetics, Pathophysiology, Clinical Presentation and Treatment
L-glutamine Approved for Sickle Cell Disease
l-glutamine, crizanlizumab, voxelotor, and cell-based therapy for adult sickle cell disease: Hype or hope? - ScienceDirect
l-Glutamine for sickle cell anemia: more questions than answers - ScienceDirect
A New Step in the Treatment of Sickle Cell Disease | Biochemistry
Endari
Voxelotor versus other therapeutic options for sickle cell disease: Are we still lagging behind in treating the disease? - Tayyaba Rehan - 2022 - Health Science Reports - Wiley Online Library
Frontiers | In utero Therapy for the Treatment of Sickle Cell Disease: Taking Advantage of the Fetal Immune System
Published human studies of L-glutamine for SCA | Download Table
Frontiers | Recent Advances in the Treatment of Sickle Cell Disease
A Phase 3 Trial of l-Glutamine in Sickle Cell Disease | NEJM
NEJM on X: "Original Article and Quick Take video summary: A Phase 3 Trial of L-Glutamine in #SickleCell Disease https://t.co/AHPtjXdcRO https://t.co/l4h3UHz6jU" / X
Study shows L-Glutamine is effective and safe in fighting sickle cell pain attacks - School of Medicine News - Wayne State University
l-glutamine, crizanlizumab, voxelotor, and cell-based therapy for adult sickle cell disease: Hype or hope? - ScienceDirect
5 Pearls On Sickle Cell | Core IM Podcast
l-Glutamine for sickle cell anemia: more questions than answers - ScienceDirect
Everything you need to know about Sickle Cell Anaemia - Apollo Hospital - Best Hospital in Mumbai
Pharmacy | Free Full-Text | Recent Advances in Sickle-Cell Disease Therapies: A Review of Voxelotor, Crizanlizumab, and L-glutamine
A Phase 3 Trial of l-Glutamine in Sickle Cell Disease | NEJM
L-glutamine for sickle cell disease: more than reducing redox | Annals of Hematology
Understanding Sickle Cell Disease
L-glutamine for sickle cell disease: Knight or pawn? | Semantic Scholar
Therapeutic strategies for sickle cell disease: towards a multi-agent approach | Nature Reviews Drug Discovery
Biomedicines | Free Full-Text | Long-Term L-Glutamine Treatment Reduces Hemolysis without Ameliorating Hepatic Vaso-Occlusion and Liver Fibrosis in a Mouse Model of Sickle Cell Disease
